Date | For | Estimate | Reported | Surprise | surprise % |
---|---|---|---|---|---|
2024-09-25 | 2024-06 | 0 | N/A | N/A | N/A |
2024-05-15 | 2024-03 | 0 | -0.52 | N/A | N/A |
2024-02-14 | 2023-12 | 0 | -0.04 | N/A | N/A |
2023-11-14 | 2023-09 | 0 | -1.48 | N/A | N/A |
2023-09-27 | 2023-06 | 0 | 0.16 | N/A | N/A |
2023-05-11 | 2023-03 | 0 | -1.93 | N/A | N/A |
Date | Firm | Action | From | To |
---|---|---|---|---|
2023-08-08 | Maxim Group | Upgrade | Buy | |
2023-05-30 | HC Wainwright & Co. | Upgrade | Buy | Buy |
Date | Name | Relation | Quantity | Description |
---|---|---|---|---|
2021-04-15 | CANTRELL GARY V. | Director | 204.09K | Stock Award(Grant) |
2023-06-13 | DISBROW JOSHUA R. | Chief Executive Officer | 71.59K | Purchase |
2023-08-10 | DOCKERY CARL C | Director | 8.94K | Stock Award(Grant) |
2021-04-07 | HECHT BETH P | Director | 9.05K | Stock Award(Grant) |
2023-08-15 | JAIN ABHINAV | Director | 8.00K | Stock Award(Grant) |
2023-08-10 | LIU VIVIAN H | Director | 1.84K | Stock Award(Grant) |
Report Date | Organization | Position | Value | Percentage |
---|---|---|---|---|
2023-06-29 | Nantahala Capital Management, LLC | 1.09M | 1.74M | 19.65% |
2023-06-29 | Stonepine Capital Management, LLC | 472.37K | 755.79K | 8.54% |
2023-06-29 | Renaissance Technologies, LLC | 57.32K | 91.72K | 1.04% |
2023-06-29 | Blackrock Inc. | 24.06K | 38.49K | 0.44% |
2023-06-29 | Acadian Asset Management. LLC | 22.54K | 36.06K | 0.41% |
2023-06-29 | Prudential Financial, Inc. | 19.58K | 31.32K | 0.35% |
Report Date | Organization | Position | Value | Percentage |
---|---|---|---|---|
2023-06-29 | Vanguard Extended Market Index Fund | 9.99K | 15.99K | 0.18% |
2023-05-30 | Fidelity Extended Market Index Fund | 8.71K | 14.55K | 0.16% |
2023-05-30 | Fidelity Series Total Market Index Fund | 1.59K | 2.66K | 0.03% |
2023-05-30 | Fidelity Total Market Index Fund | 1.59K | 2.65K | 0.03% |
2023-08-30 | iShares Core S&P Total U.S. Stock Market ETF | 1.27K | 2.15K | 0.02% |
Split | Date |
---|---|
1 : 20 | 2023-01-06 |
1 : 10 | 2020-12-09 |
1 : 20 | 2018-08-13 |
1 : 20 | 2017-08-29 |
1 : 12 | 2016-07-01 |
82 : 1000 | 2015-06-10 |
-
Back to 1.60
I will buy in on that price.
Great Future outlook and the barcode makes it easy to sell and buy back in. See you tomorrow for buy back in of 1.55 to 1.60 -
Give a little flavour
-
Transformative
-
-
2$$$$ so longgggg yeahhh
-
Dont worry this is a Bull room.
Those selling cheap are not long term investors.Less get the after hours numbers before we decide.
I have a feeling it will be very informative and will see the newspaper go crazy Friday morning.
Lots of press coverage for us! -
-
-
Lot of BULL in here just day traders will hurt us selling to low. Bouncing the .10 cent thing I see over stocks.
-
Need know worries about 2 that is easy to forecast and see. 2 by noon is easy. If this stock is not over 2 by noon we should worry some. I see $2.15 today before press release or higher.
-
Waz up AYTU . Stocktwits kick me out @Lifeontheline for i dont’t fucking know why ?
Good to be back on AYTU i told ya il be back . Bought 12k shares yesterday to push it up at 1.69
Cmon JoSh bring us some big doo -
Wow busy time and good sign as almost 11m in trades before market. Definitely hitting 2 dollars this morning and then we will see how it goes today.
I’m in for the after hours and camped hard.
SHOW ME THE MONEY!
SHOW ME THR MONEY!Good luck and may we all haves delightful public news event.
-
Yes I think the kit will get FDA approval.
This is pure politics and political money in my book.Since the test was not American made it has not received approval. Hopefully AYTU figures out how to make the test in the USA. That will be big news!
-
Lol funny
Good luck Shorts hopefully you dont get a big bill -
Hoping everyone sets the limit to five dollars are more the rest of the week.
-
-
-
Nice cup and handle chart $$$$$
-
Im back after couples of weeks . Bar code misse me so much lol .
-
Aytu BioPharma, Inc. (AYTU) Q3 2024 Earnings Call Transcript
seekingalpha.com • -
Aytu BioPharma, Inc. (AYTU) Q2 2024 Earnings Call Transcript
seekingalpha.com • -
Aytu BioPharma, Inc. (AYTU) Q1 2024 Earnings Call Transcript
seekingalpha.com • -
Aytu BioPharma Reports Fiscal 2024 First Quarter Financial Results
accesswire.com • -
Best Penny Stocks? 4 Hot Stocks With News This Week
pennystocks.com • -
Aytu BioPharma, Inc. (AYTU) Q4 2023 Earnings Call Transcript
seekingalpha.com •